LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

Home・Aktien・PROCEPT BioRobotics Corp

Search

PROCEPT BioRobotics Corp

Geschlossen

BrancheGesundheitswesen

28.89 0.35

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

28.09

Max

29.38

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.8M -32M
Verkäufe	6.7M 83M
EPS	-0.56
Gewinnspanne	-38.058
Angestellte	888
EBITDA	-9.1M -31M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+16.99% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	5. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	250M 1.6B
Vorheriger Eröffnungskurs	28.54
Vorheriger Schlusskurs	28.89

Nachrichtenstimmung

By Acuity

50%

50%

154 / 344 Ranking in Healthcare

PROCEPT BioRobotics Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Juni 2026, 23:36 UTC

Ergebnisse

Correction to Oracle Reports Higher 4Q Profit Article

10. Juni 2026, 23:19 UTC

Heiße Aktien

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

10. Juni 2026, 23:09 UTC

Wichtige Markttreiber

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

10. Juni 2026, 23:04 UTC

Ergebnisse

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

10. Juni 2026, 20:44 UTC

Wichtige Markttreiber

Caterpillar Raises Quarterly Dividend 8%

10. Juni 2026, 23:49 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Northern Star Should Take No Options Off The Table

10. Juni 2026, 23:48 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

10. Juni 2026, 23:48 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

10. Juni 2026, 23:47 UTC

Market Talk

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

10. Juni 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

10. Juni 2026, 23:46 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

10. Juni 2026, 23:38 UTC

Market Talk

Global Equities Roundup: Market Talk

10. Juni 2026, 23:38 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10. Juni 2026, 23:38 UTC

Market Talk

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

10. Juni 2026, 23:32 UTC

Market Talk

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

10. Juni 2026, 23:20 UTC

Market Talk

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

10. Juni 2026, 22:05 UTC

Market Talk

Correction to Bank of Canada Stays on Hold Market Talk

10. Juni 2026, 21:57 UTC

Ergebnisse

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. Juni 2026, 21:52 UTC

Ergebnisse

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. Juni 2026, 21:35 UTC

Ergebnisse

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. Juni 2026, 21:22 UTC

Ergebnisse

Oracle Stock Slides on Increased Capital Spending -- WSJ

10. Juni 2026, 20:50 UTC

Market Talk

Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

10. Juni 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10. Juni 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10. Juni 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10. Juni 2026, 20:39 UTC

Market Talk

Ergebnisse

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

10. Juni 2026, 20:34 UTC

Ergebnisse

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. Juni 2026, 20:33 UTC

Ergebnisse

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

10. Juni 2026, 20:33 UTC

Market Talk

Ergebnisse

Global Equities Roundup: Market Talk

10. Juni 2026, 20:33 UTC

Market Talk

Ergebnisse

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

Peer-Vergleich

Kursveränderung

PROCEPT BioRobotics Corp Prognose

Kursziel

By TipRanks

16.99% Vorteil

12-Monats-Prognose

Durchschnitt 33.67 USD 16.99%

Hoch 51 USD

Tief 20 USD

Basierend auf 9 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für PROCEPT BioRobotics Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

9 ratings

6

Buy

2

Halten

1

Sell

Basierend auf 9 Analysten, die in den letzten 3 Monaten Aktienbewertungen für PROCEPT BioRobotics Corp – Dist abgegeben haben.

Stimmung

By Acuity

154 / 344 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Andere Aktien aus dem Sektor

LLY

Eli Lilly and Co.

1,136.41

JNJ

Johnson and Johnson

238.85

ABBV

AbbVie Inc

225.29

UNH

UnitedHealth Group Inc

407.06

MRK

Merck & Co Inc.

119

Live chat